Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
53
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy

Wenlong Zhong1 Department of Urology, Peking University First Hospital;2 Institute of Urology, Peking University;3 National Urological Cancer Center, Beijing
,
Lei Zhang1 Department of Urology, Peking University First Hospital;2 Institute of Urology, Peking University;3 National Urological Cancer Center, Beijing
,
Jiajian Ma4 Peking University Health Science Center, Beijing
,
Shan Shao5 Neuroscience Research Institute, Peking University, Beijing, China
,
Rongcheng Lin1 Department of Urology, Peking University First Hospital;2 Institute of Urology, Peking University;3 National Urological Cancer Center, Beijing
,
Xuesong Li1 Department of Urology, Peking University First Hospital;2 Institute of Urology, Peking University;3 National Urological Cancer Center, BeijingCorrespondence[email protected] [email protected]
,
Gengyan Xiong1 Department of Urology, Peking University First Hospital;2 Institute of Urology, Peking University;3 National Urological Cancer Center, Beijing
,
Dong Fang1 Department of Urology, Peking University First Hospital;2 Institute of Urology, Peking University;3 National Urological Cancer Center, Beijing
&
Liqun Zhou1 Department of Urology, Peking University First Hospital;2 Institute of Urology, Peking University;3 National Urological Cancer Center, BeijingCorrespondence[email protected] [email protected]
 show all
Pages 5775-5782 | Published online: 05 Dec 2017

References

  • RoupretMBabjukMComperatEEuropean association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 updateEur Urol201568586887926188393
  • SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
  • MargulisVShariatSFMatinSFOutcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaborationCancer200911561224123319156917
  • NortierJLMartinezMCSchmeiserHHUrothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)N Engl J Med2000342231686169210841870
  • IARC Working Group on the Evaluation of Carcinogenic Risks to HumansSome traditional herbal medicines, some mycotoxins, naphthalene and styreneIARC Monogr Eval Carcinog Risks Hum200282155612687954
  • WuFWangTRisk assessment of upper tract urothelial carcinoma related to aristolochic acidCancer Epidemiol2013225812820
  • DebelleFDVanherweghemJLNortierJLAristolochic acid nephropathy: a worldwide problemKidney Int200874215816918418355
  • JelakovicBKaranovicSVukovic-LelaIAristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acidKidney Int201281655956722071594
  • ChenCHDickmanKGMoriyaMAristolochic acid-associated urothelial cancer in TaiwanProc Natl Acad Sci U S A2012109218241824622493262
  • LaiMNWangSMChenPCChenYYWangJDPopulation-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer riskJ Natl Cancer Inst2010102317918620026811
  • CukuranovicRIgnjatovicIVisnjicMCharacteristics of upper urothelial carcinoma in an area of Balkan endemic nephropathy in south Serbia. A fifty-year retrospective studyTumori201096567467921302610
  • ChenCHDickmanKGHuangCYAristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomesInt J Cancer2013133114s20s
  • National Pharmacopoeia CommitteeThe Pharmacopoeia of People’s Republic of China1st edBeijingChemical Industry Press2000
  • China Food and Drug AdministrationNotice on the cancellation of the medicinal use of Guan Mu Tong, No. 121 [in Chinese] Available from: http://www.sda.gov.cn/WS01/CL0844/9977.htmlAccessed April 1, 2003
  • China Food and Drug AdministrationNotice on Strengthening the Supervision and Management on the Use and Production of Guang Fangchi and Five Other Herbs, No. 379 [in Chinese] Available from: http://www.sda.gov.cn/WS01/CL0844/10242.htmlAccessed August 5, 2004
  • ZhangLXiongGFangDContralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylationJ Exp Clin Cancer Res201534525613404
  • LemyAWissingKMRoriveSLate onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-upAm J Kidney Dis200851347147718295063
  • LughezzaniGSunMPerrottePGender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results databaseUrology201075232132719962727
  • ChenXPXiongGYLiXSPredictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in ChinaBJU Int2013112791792423905945
  • ChenCHDickmanKGHuangCYRecurrence pattern and TP53 mutation in upper urinary tract urothelial carcinomaOncotarget2016729452254523627286260
  • MiyakeHHaraIKamidonoSEtoHMultifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patternsJ Urol200417231127112915311055
  • FangDLiuPLiXCharacteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patientsSci Rep201551801426657777
  • LiWHYangLSuTSongYLiXMInfluence of taking aristolochic acid-containing Chinese drugs on occurrence of urinary transitional cell cancer in uremic uremic patients undergoing dialysisZhonghua Yi Xue Za Zhi2005853524872491 Chinese16321276

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.